A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
American Journal of Gastroenterology - United States
doi 10.1038/ajg.2012.255
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)